130 related articles for article (PubMed ID: 8438240)
1. CD4+ T-cell-dependent destruction of MHC class I disparate cardiac allografts.
Morton AL; Bolton EM; Lawes CM; Porteous C; Bradley JA
Transplant Proc; 1993 Feb; 25(1 Pt 1):102-3. PubMed ID: 8438240
[No Abstract] [Full Text] [Related]
2. Role of interleukin-2-producing CD4+ T cells in acute rejection of class I major histocompatibility complex disparate rat heart allografts.
Ito T; Stepkowski SM; Shirakura R; Nakata S; Yamamoto S; Nozaki S; Miyata M; Matsuda H
Transplant Proc; 1993 Feb; 25(1 Pt 2):885-7. PubMed ID: 8442257
[No Abstract] [Full Text] [Related]
3. The role of CD4+ and CD8+ T cells in rejection of class I MHC disparate renal allografts.
Bradley JA; Gracie JA; Porteous C; Bolton EM
Transplant Proc; 1991 Feb; 23(1 Pt 1):266-7. PubMed ID: 1899304
[No Abstract] [Full Text] [Related]
4. CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.
Morton AL; Bell EB; Bolton EM; Marshall HE; Roadknight C; McDonagh M; Bradley JA
Eur J Immunol; 1993 Sep; 23(9):2078-84. PubMed ID: 8103742
[TBL] [Abstract][Full Text] [Related]
5. Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.
Fangmann J; Dalchau R; Fabre JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):183-4. PubMed ID: 8438266
[No Abstract] [Full Text] [Related]
6. Role of T-cell subsets in rat liver allograft rejection.
Yokoi Y; Sumimoto R; Yamaguchi A; Baba S; Nakamura S; Kimura H
Transplant Proc; 1993 Apr; 25(2):1994-6. PubMed ID: 8470255
[No Abstract] [Full Text] [Related]
7. Contribution of CD4+ cells to allorejection across a class I major histocompatibility complex barrier in congeneic rats.
Stepkowski SM; Goto S; Wiggins J; Christopher J; Kahan BD
Transplant Proc; 1991 Feb; 23(1 Pt 1):172-3. PubMed ID: 1990506
[No Abstract] [Full Text] [Related]
8. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T-cell removal reduces survival of minor antigen mismatched islet allografts (CBA-->C3H) in mice treated with anti-CD4 monoclonal antibody.
Koulmanda M; Mandel TE
Transplant Proc; 1992 Oct; 24(5):2297-8. PubMed ID: 1413065
[No Abstract] [Full Text] [Related]
10. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
11. In vivo immunosuppressive effects of monoclonal antibodies specific for CD3+, CD4+, CD8+, and MHC class II positive cells.
Stevens HP; Roche N; Hovius SE; Jonker M
Transplant Proc; 1990 Aug; 22(4):1783-4. PubMed ID: 2143861
[No Abstract] [Full Text] [Related]
12. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
13. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
Krieger NR; Fathman CG
J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
[No Abstract] [Full Text] [Related]
14. A comparison of lymphocytic subsets participating in concordant cardiac xenograft and acute cardiac allograft rejection.
Cramer DV; Wu GD; Chapman FA; Wang HK; Cajulis E; Makowka L
Transplant Proc; 1992 Apr; 24(2):533-4. PubMed ID: 1566419
[No Abstract] [Full Text] [Related]
15. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
16. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
[No Abstract] [Full Text] [Related]
17. Role of CD4+ and CD8+ T cells in proislet allograft and xenograft rejection.
Simeonovic CJ; Wilson JD
Transplant Proc; 1992 Feb; 24(1):252-3. PubMed ID: 1539270
[No Abstract] [Full Text] [Related]
18. The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells/CD4+CD25- T cells determines rejection or tolerance.
Nomura M; Plain KM; Verma N; Robinson C; Boyd R; Hodgkinson SJ; Hall BM
Transpl Immunol; 2006 Apr; 15(4):311-8. PubMed ID: 16635754
[TBL] [Abstract][Full Text] [Related]
19. Donor-specific transplantation unresponsiveness in sensitized rats following treatment with a nondepleting anti-CD4 MAb is associated with selective intragraft sparing of Th2-like cells.
Binder J; Hancock WW; Wasowska B; Gallon L; Watschinger B; Sayegh MH; Brock J; Lehmann M; Volk HD; Kupiec-Weglinski JW
Transplant Proc; 1995 Feb; 27(1):114-6. PubMed ID: 7878825
[No Abstract] [Full Text] [Related]
20. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression.
Saitovitch D; Morris PJ; Wood KJ
Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
